Screening for Neuroligin 4 (NLGN4) truncating and transmembrane domain mutations in schizophrenia.
Sand
P
P
Langguth
B
B
Hajak
G
G
Perna
M
M
Prikryl
R
R
Kucerova
H
H
Ceskova
E
E
Kick
C
C
Stoertebecker
P
P
Eichhammer
P
P
D000328:Adult; D000483:Alleles; D002352:Carrier Proteins / Q000235:genetics*; D015816:Cell Adhesion Molecules, Neuronal; D002874:Chromosome Mapping; D041321:Chromosomes, Human, X; D041322:Chromosomes, Human, Y; D004252:DNA Mutational Analysis; D005091:Exons; D005260:Female; D005820:Genetic Testing; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D010641:Phenotype; D010865:Pilot Projects; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D015203:Reproducibility of Results; D012559:Schizophrenia / Q000145:classification / Q000175:diagnosis / Q000235:genetics*; D013223:Statistics as Topic
D002352:Carrier Proteins; D015816:Cell Adhesion Molecules, Neuronal; D008565:Membrane Proteins; C430845:NLGN4X protein, human